from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0528/-

LFCtreatmentdescriptionclass of inhibitor

-1.474

Amikacinug/mL Amikacintranslation

-2.175

Cap5-10ug/mL Capreomycintranslation

-1.935

Rox10-50 ug/mL Roxithromycintranslation

-0.724

SM2-5 ug/mL Streptomycintranslation

-2.343

Tet5-10 ug/mL Tetracyclinetranslation

-0.245

Rif0.2-5ug/mL Rifampicintranscription

-0.271

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.033

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.616

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.343

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.303

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.127

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.383

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.731

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.171

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.541

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.105

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.324

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.725

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.364

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.620

KCN5-20 ug/mL Potassium cyaniderespiration

0.754

NaN30.2-2 mM Sodium aziderespiration

-0.357

Nigericin50 uM Nigericinrespiration

-0.247

TRC10-150 ug/mL Triclosanrespiration

0.324

TRZ10-25 ug/mL Thioridazinerespiration

-1.751

Valinomycin0.5-10 uM Valinomycinrespiration

-0.187

ZnSO42 mM ZnSO4respiration

-0.368

menadione6-10 ug/mL Menadionerespiration

-0.361

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.056

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.546

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.420

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.422

NRP_1Non-replicating persistence stage 1dosRassociated

0.146

Amp0.2mg/mL AmpicillincellWall

0.239

Cephalexin20-100 ug/mL CephalexincellWall

-0.070

Cerulenin0.32-5 ug/mL CerulenincellWall

0.308

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.178

EMB10-20 ug/mL EthambutolcellWall

0.409

Eta12-40 ug/mL EthionamidecellWall

0.747

INH0.2-0.4 ug/mL IsoniazidcellWall

0.132

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.778

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.743

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.456

BZA0.12 mg/mL BenzamidearomaticAmides

-0.106

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.022

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.148

H2O24 mM hydrogen peroxideDNAdamaging

-0.147

Levo10 ug/mL LevofloxacinDNAdamaging

0.070

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.585

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.161

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.019

UVUV-irradiationDNAdamaging

0.739

ARP41-4 ug/mL Antitubercular compound ARP4?

0.001

Antimycin12.5-50 ug/mL Antimycin A?

-0.297

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.352

PA_110-50 ug/mL Antitubercular compound PA-1?

0.664

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.773

PA8240.2-2 ug/mL PA-824?

1.208

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.309

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.431

Verapamil50 uM Verapamil?

-0.119

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.468

methoxatin10-20 ug/mL Methoxatin?